Chatbot-delivered Theory-based Online Intervention in Increasing Seasonal Influenza Vaccination Uptake Among Children Aged 3-6 Years
A Randomized Controlled Trial Evaluating a Chatbot-delivered Theory-based Online Intervention in Increasing Seasonal Influenza Vaccination Uptake Among Children Aged 3-6 Years
This randomized controlled trial will compare the efficacy of a Chatbot-delivered stage-of-change-tailored online intervention versus a Chatbot-delivered non-stage-of-change-tailored online intervention for mothers in increasing seasonal influenza vaccination uptake of their children aged 3-6 years. Mothers of children aged 3-6 years will be randomized evenly into either the intervention or the control group.
In the intervention group, the Chatbot will assess mothers' stage of change regarding their children's seasonal influenza vaccination uptake and deliver SOC-tailored interventions through WhatsApp every two weeks for four times.
In the control group, the Chatbot will provide a standard and non-stage-of-change-tailored intervention every two weeks for four times.
All participants will complete three telephone surveys at baseline (T0), after completion of the intervention (T1) and three months after T1 (T2).
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
- Naam: Zixin Wang, PhD
- Telefoonnummer: +852 22528474
- E-mail: wangzx@cuhk.edu.hk
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Beschrijving
Inclusion Criteria:
- Mothers aged ≥18 years with at least one child aged 3-6 years studying in kindergarten in Hong Kong
- Cantonese speaking
- Having smartphone with internet access
- Already having WhatsApp on the smartphone
Exclusion Criteria:
- Blindness or deafness
- The index child has known medical contraindications for seasonal influenza vaccination
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Onderzoek naar gezondheidsdiensten
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Intervention group
Participants in the intervention group will receive chatbot-delivered online interventions tailored to their current stage of change regarding their index child's seasonal influenza vaccination.
|
The Chatbot will deliver four intervention sessions tailored to participants' current stage of change regarding their index child's seasonal influenza vaccination uptake at Week 0, 2, 4, and 6.
Participants will also have access to real-time Question-and-Answer (QA) function provided by the chatbot to address their questions related to seasonal influenza vaccination during the intervention period (week 0-6), and they are free to spend as much time as they want on such function.
|
|
Actieve vergelijker: Control group
Participants in the control group will receive chatbot-delivered standard and non-stage-of-change-tailored interventions
|
The Chatbot will automatically send participants a link to access a standard online video at week 0, 2, 4 and 6.
Participants will also have access to real-time Question-and-Answer (QA) function provided by the chatbot to address their questions related to seasonal influenza vaccination during the intervention period (week 0-6), and they are free to spend as much time as they want on such function.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Index child's seasonal influenza vaccination uptake reported by his/her mother with validation
Tijdsspanne: 3 months after completion of the interventions (T2)
|
The research team will ask the participants whether their index children have taken up seasonal influenza vaccination at T2 (3 months after completion of the interventions) using a validated question through telephone interview.
The research team will validate the outcome by requesting participants uploading an image of SIV receipt, while hiding personal identification, via the WhatsApp account used in this project.
|
3 months after completion of the interventions (T2)
|
Medewerkers en onderzoekers
Sponsor
Studie record data
Bestudeer belangrijke data
Studie start (Geschat)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Andere studie-ID-nummers
- HMRF24230092
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .